These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29457212)

  • 1. A Case of Alpha-Fetoprotein-Producing Adenocarcinoma of the Esophagogastric Junction in which Long-Term Survival Was Achieved by Means of Individualized Multidisciplinary Therapy.
    Tanaka K; Fujiya M; Ijiri M; Takahashi K; Ando K; Nomura Y; Ueno N; Kashima S; Goto T; Sasajima J; Ito T; Moriichi K; Mizukami Y; Tanabe H; Okumura T
    J Gastrointest Cancer; 2019 Sep; 50(3):617-620. PubMed ID: 29457212
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis and treatment of non-metastatic esophagogastric junction adenocarcinoma: what are the current options?
    Gronnier C; Piessen G; Mariette C
    J Visc Surg; 2012 Feb; 149(1):e23-33. PubMed ID: 22341763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Surg Oncol; 2000 Jul; 9(1):35-41. PubMed ID: 11525305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy for Esophageal Adenocarcinoma.
    Lam KO; Kwong DLW
    Methods Mol Biol; 2018; 1756():19-34. PubMed ID: 29600357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
    Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
    World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pure hepatoid adenocarcinoma of the stomach with spleen and lymph-node metastases.
    Lu CC; De-Chuan C; Lee HS; Chu HC
    Am J Surg; 2010 Apr; 199(4):e42-4. PubMed ID: 20359564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-fetoprotein expressing metastastic adenocarcinoma of the esophago-gastric junction responding favorably to capecitabine and oxaliplatin.
    Kripp M; Ströbel P; Dinter D; Lukan N; Hochhaus A; Hofheinz RD
    Anticancer Drugs; 2009 Jan; 20(1):75-8. PubMed ID: 19343004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of gastroesophageal junction tumors.
    Fox MP; van Berkel V
    Surg Clin North Am; 2012 Oct; 92(5):1199-212. PubMed ID: 23026278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI.
    Al-Batran SE; Goetze TO; Mueller DW; Vogel A; Winkler M; Lorenzen S; Novotny A; Pauligk C; Homann N; Jungbluth T; Reissfelder C; Caca K; Retter S; Horndasch E; Gumpp J; Bolling C; Fuchs KH; Blau W; Padberg W; Pohl M; Wunsch A; Michl P; Mannes F; Schwarzbach M; Schmalenberg H; Hohaus M; Scholz C; Benckert C; Knorrenschild JR; Kanngießer V; Zander T; Alakus H; Hofheinz RD; Roedel C; Shah MA; Sasako M; Lorenz D; Izbicki J; Bechstein WO; Lang H; Moenig SP
    BMC Cancer; 2017 Dec; 17(1):893. PubMed ID: 29282088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of AFP-producing esophagogastric junction cancer with liver metastases with a good response to chemotherapy].
    Nagai Y; Kato T; Harano M; Satoh D; Choda Y; Tokumoto N; Kanazawa T; Matsukawa H; Ojima Y; Idani H; Shiozaki S; Okajima M; Ninomiya M; Ohno S
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2349-51. PubMed ID: 25731519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study.
    Xu H; Zhang L; Miao J; Liu S; Liu H; Jia T; Zhang Q
    World J Surg Oncol; 2020 Jun; 18(1):144. PubMed ID: 32593312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroesophageal Cancer During Pregnancy: a Case Report and Review of the Literature.
    Bozkurt M; Antonoff M; Jaramillo S; Sagebiel T; Murphy MB
    J Gastrointest Cancer; 2019 Sep; 50(3):634-640. PubMed ID: 29577180
    [No Abstract]   [Full Text] [Related]  

  • 13. Siewert III adenocarcinoma: treatment update.
    Di Leo A; Zanoni A
    Updates Surg; 2017 Sep; 69(3):319-325. PubMed ID: 28303519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status and challenges of clinical trial on adenocarcinoma of esophagogastric junction].
    Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):112-118. PubMed ID: 30799533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma: Postoperative chemotherapy has a substantial impact on outcome.
    Glatz T; Bronsert P; Schäfer M; Kulemann B; Marjanovic G; Sick O; Hopt UT; Zirlik K; Makowiec F; Hoeppner J
    Eur J Surg Oncol; 2015 Oct; 41(10):1300-7. PubMed ID: 26253194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical Resection for a Metachronous Liver Metastasis of an Esophagogastric Junction Adenocarcinoma].
    Tada T; Kikuchi T; Watanabe J; Sato N; Hanayama H; Endo H; Anazawa T; Saze Z; Kimura T; Osuka F; Kenjo A; Kawana S; Tasaki K; Hashimoto Y; Gotoh M
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1617-9. PubMed ID: 26805115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Siewert III Adenocarcinoma: Still Searching for the Right Treatment Combination.
    Tang A; Sohal D; McNamara M; Murthy SC; Raja S
    Surg Oncol Clin N Am; 2020 Oct; 29(4):647-653. PubMed ID: 32883464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal management of esophageal adenocarcinoma: should we be CROSS?
    Smyth EC; Waddell TS; Cunningham D
    J Clin Oncol; 2014 Sep; 32(27):3080-1. PubMed ID: 25071100
    [No Abstract]   [Full Text] [Related]  

  • 19. A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma.
    Park I; Ryu MH; Choi YH; Kang HJ; Yook JH; Park YS; Kim HJ; Jung HY; Lee GH; Kim KC; Kim BS; Kang YK
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):815-23. PubMed ID: 23921575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Understanding and controversy of the gastroesophageal junction adenocarcinoma].
    Zhang XH; Wang QZ
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):947-9. PubMed ID: 19174001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.